| pubmed-article:15908658 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0817096 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
| pubmed-article:15908658 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:15908658 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:15908658 | pubmed:dateCreated | 2005-5-23 | lld:pubmed |
| pubmed-article:15908658 | pubmed:abstractText | Irinotecan plus cisplatin (IP) chemotherapy demonstrated a promising outcome with a high complete response (CR) rate in chemotherapy-naïve patients with extensive small-cell lung cancer (SCLC). We evaluated the efficacy of induction IP chemotherapy followed by concurrent etoposide plus cisplatin (EP) chemotherapy with twice-daily thoracic radiotherapy (TDTRT) in limited-disease SCLC (LD-SCLC). | lld:pubmed |
| pubmed-article:15908658 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15908658 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15908658 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15908658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15908658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15908658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15908658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15908658 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15908658 | pubmed:month | May | lld:pubmed |
| pubmed-article:15908658 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:BooksC ACA | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:KimEun-AEA | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:KimHyae... | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:HanJi-YounJY | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:LeeDae HoDH | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:LeeSung... | lld:pubmed |
| pubmed-article:15908658 | pubmed:author | pubmed-author:ChoKwan HoKH | lld:pubmed |
| pubmed-article:15908658 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15908658 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:15908658 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:15908658 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15908658 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15908658 | pubmed:pagination | 3488-94 | lld:pubmed |
| pubmed-article:15908658 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:meshHeading | pubmed-meshheading:15908658... | lld:pubmed |
| pubmed-article:15908658 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15908658 | pubmed:articleTitle | Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer. | lld:pubmed |
| pubmed-article:15908658 | pubmed:affiliation | Research Institute & Hospital, National Cancer Center, Goyang, Gyeonggi, Korea. | lld:pubmed |
| pubmed-article:15908658 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15908658 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15908658 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15908658 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15908658 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15908658 | lld:pubmed |
